Abstract
The title compound (6), its structure being imaginatively created, has been prepared through coupling of alizarine blue (2), a classical dye, and 3,4-di-O-acetyl-2,6-dideoxy-2-fluoro-alpha-L-talopyranosyl bromide (3). Compound 6 has considerably higher and different antitumor activity from that of doxorubicin or its analogue (10), and, further, has properties to reverse multidrug resistance (by P-glycoprotein), to inhibit topoisomerase II, and to induce apoptosis.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Antineoplastic Agents / chemical synthesis*
-
Antineoplastic Agents / pharmacology
-
Drug Screening Assays, Antitumor
-
Glycosides / chemical synthesis*
-
Glycosides / pharmacology
-
Mice
-
Naphthoquinones / chemical synthesis*
-
Naphthoquinones / pharmacology
-
Tumor Cells, Cultured
Substances
-
5-(2,6-dideoxy-2-fluorotalopyranosyloxy)-6-hydroxynaphtho(2,3-f)quinoline-7,12-dione
-
Antineoplastic Agents
-
Glycosides
-
Naphthoquinones